This inventor holds 14 USPTO granted patents, primarily in Apolipoprotein Agonists. Top assignees: Esperion Therapeutics, Inc., Pfizer Corporation, Other. Active years: 1999-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 60 
1 out of 4,490 
11 out of 834,659 Years Active: 1999-2007
Areas of Expertise:
Title: Innovations of Jean Dufourcq in Pharmaceutical Research
Introduction
Jean Dufourcq is a distinguished inventor based in Pessac, France, with an impressive portfolio of 14 patents. His work primarily focuses on pharmaceutical compositions, particularly in the area of treating dyslipidemic disorders. His innovative contributions have the potential to significantly impact the field of medicine.
Latest Patents
Among Jean's latest patents are two noteworthy inventions:
1. **Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders** - This invention outlines the development of peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. These compounds are intended to address a variety of disorders associated with dyslipidemia.
2. **Multimeric Apo A-I agonist compounds** - Similar to the first patent, this invention also focuses on peptides and peptide analogues that replicate the essential characteristics of human ApoA-I, providing new avenues for treating dyslipidemic conditions.
Career Highlights
Jean Dufourcq's career is marked by his innovative research and contributions to the pharmaceutical industry. He has worked with reputable organizations, including Esperion Therapeutics, Inc., where his expertise has led to advancements in therapeutic solutions targeting lipid metabolism disorders.
Collaborations
Throughout his career, Jean has collaborated with notable professionals such as Jean-Louis Henri Dasseux and Renate Sekul. These collaborations have fostered an environment of innovation and have further propelled his research efforts in the field of pharmaceuticals.
Conclusion
In conclusion, Jean Dufourcq's work exemplifies the spirit of innovation within the pharmaceutical sector. With 14 patents to his name, his contributions, particularly in developing treatments for dyslipidemic disorders, showcase the vital role inventors play in advancing medical science. Jean's ongoing research and collaborations continue to inspire future innovations in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile